Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Similar documents
Role of Whole-Body Diffusion-Weighted MR in Assessment of Neoplastic Leisons

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Prostate Case Scenario 1

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

A 64 y.o. man presents to the hospital with persistent cough and hemoptysis. Fernando Mut Montevideo - Uruguay

F NaF PET/CT in the Evaluation of Skeletal Malignancy

Imaging in gastric cancer

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

HEALTHFIRST 2011 RADIOLOGY PROGRAM CODE LIST

Case Report Solitary Osteolytic Skull Metastasis in a Case of Unknown Primary Being latter Diagnosed as Carcinoma of Gall Bladder

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

CPT CODES. Ph: (307) Fax: (307) CATSCAN IV Contrast: 87.00

Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results

Staging Colorectal Cancer

FieldStrength. Leuven research is finetuning. whole body staging

Imaging of bone metastases

Case Scenario 1. 4/19/13 Bone Scan: No scintigraphic findings to suggest skeletal metastases.

Disclosure. Acknowledgement. What is the Best Workup for Rectal Cancer Staging: US/MRI/PET? Rectal cancer imaging. None

primary (CUP) syndrome

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Institution INSTRUCTIONS (I6) 1. This form is to be completed by a DESIGNATED STUDY NUCLEAR MEDICINE SPECIALIST

Cervical Cancer: 2018 FIGO Staging

PET/CT Frequently Asked Questions

Using PET/CT in Prostate Cancer

Radiological / Imaging Services Fee Schedule Provider Specialty 093

Institution INSTRUCTIONS (M3) - All other imaging studies, including CT, CONVENTIONAL MRI, PET SCINTIGRAPHY, etc... AND

ORIGINAL ARTICLE ABSTRACT

Update on RECIST and Staging of Common Pediatric Tumors Ethan A. Smith, MD

Whole body Diffusion Weighted MRI (WB-DWI) in the assessment and treatment response of multiple myeloma (MM).

HIP RADIOLOGY PROGRAM CODE LISTS

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Lung. 10/24/13 Chest X-ray: 2.9 cm mass like density in the inferior lingular segment worrisome for neoplasm. Malignancy cannot be excluded.

MRI XR, CT, NM. Principal Modality (2): Case Report # 2. Date accepted: 15 March 2013

Principles of nuclear metabolic imaging. Prof. Dr. Alex Maes AZ Groeninge Kortrijk and KULeuven Belgium

Ryan Niederkohr, M.D. Slides are not to be reproduced without permission of author

PET imaging of cancer metabolism is commonly performed with F18

POSITRON EMISSION TOMOGRAPHY (PET)

Research Article Prevalence of Clinically Significant Extraosseous Findings on Unenhanced CT Portions of 18 F-Fluoride PET/CT Bone Scans

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

Clinical indications for positron emission tomography

Case Scenario 1: Breast

1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1

Role of positron emission mammography (PEM) for assessment of axillary lymph node status in patients with breast cancer

PET IMAGING (POSITRON EMISSION TOMOGRAPY) FACT SHEET

High Resolution T2-Weighted Dixon Based Whole Body Magnetic Resonance Imaging in Detecting Bone Metastasis; Initial Results

Cigna - Prior Authorization Procedure List: Radiology & Cardiology

05/02/ CPT Preauthorization Groupings Effective May 2, Computerized Tomography (CT) Abdomen 6. CPT Description SEGR CT01

FDG-PET/CT for cancer management

CLINICAL PRESENTATION AND RADIOLOGY QUIZ QUESTION

Breast Cancer Diagnosis, Treatment and Follow-up

University of Groningen

Emerging Referral Patterns for Whole-Body Diffusion Weighted Imaging (WB-DWI) in an Oncology Center

Tumor Board Discussions: Case 1

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Nuclear medicine in oncology. 1. Diagnosis 2. Therapy

بسم هللا الرحمن الرحيم. Prof soha Talaat

SEER Summary Stage Still Here!

SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m.

High Tech Imaging Quick Reference Guide

Cancer Cases Treated and Results

Lugano classification: Role of PET-CT in lymphoma follow-up

Recommendations for cross-sectional imaging in cancer management, Second edition

AIM 2014 CPT Radiology & Cardiac Codes Requiring Review

Optimized. clinical pathway. propels high utilization of PET/MR at Pitié-Salpêtrière Hospital

Osteopoikilosis: A Sign Mimicking Skeletal Metastases in a Cancer Patient

Icd 10 code for abnormal ct scan of chest

Fast and easy diagnostic imaging from head to toe

Role of MRI Diffusion in Assessment of Malignant Mediastinal Masses

Cancer Program Report 2014

Molecular Imaging and Cancer

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

FDG-PET value in deep endometriosis

Newcastle HPB MDM updated radiology imaging protocol recommendations. Author Dr John Scott. Consultant Radiologist Freeman Hospital

Abdominal applications of DWI

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Zurich, January 19, 2018

AMERICAN IMAGING MANAGEMENT

AMERICAN IMAGING MANAGEMENT

Jeffrey C. Weinreb, MD, FACR Yale School of Medicine Yale-New Haven Hospital

Louisa Fleure. Advanced Prostate Cancer Clinical Nurse Specialist. Guys and St Thomas NHS Trust

Solitary Skull Metastasis as Initial Manifestation of Hepatocellular Carcinoma A Case Report

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

Role of MRI Diffusion in Assessment of Mediastinal Lymphadenopathy

ADI Procedure Codes. August 2016 Revised April 2017 Page 1 of 7 ADI Procedure Codes

Learning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening

Whole body F-18 sodium fluoride PET/CT in the detection of bone metastases in patients with known malignancies: A pictorial review

Unusual Osteoblastic Secondary Lesion as Predominant Metastatic Disease Spread in Two Cases of Uterine Leiomyosarcoma

Bone and CT Scans Are Complementary for Diagnoses of Bone Metastases in Breast Cancer When PET Scans Findings Are Equivocal: A Case Report

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

screening; including image post processing CT, heart; without contrast material; with Requires authorization

Quiz. b. 4 High grade c. 9 Unknown

The role of multimodality imaging in Multiple Myeloma: Past, Present and Future

Cancer of Unknown Primary (CUP)

CT Chest. Verification of an opacity seen on the straight chest X ray

Computed Tomography of Normal Adrenal Glands in Indian Population

Medical Diagnostic Imaging

RADIOLOGIC AND IMAGING SCIENCE (RIS)

Multi-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report

Transcription:

Role of Whole-body Diffusion MR in Detection of Metastatic lesions Prof. Dr. NAGUI M. ABDELWAHAB,M.D.; MARYSE Y. AWADALLAH, M.D. AYA M. BASSAM, Ms.C.

Cancer is a potentially life-threatening disease, and the development of skeletal or organ metastases is often not detected until clinical symptoms present. That is why radiological imaging such as plain film X- ray, Tc99m bone scintigraphy, computed tomography (CT), positron emission tomography (PET), magnetic resonance imaging (MRI), are the cornerstone for :- Detection and staging of metastatic lesions. Classifying their type, site and extent. Skeletal scintigraphy is the standard procedure for visualizing bone metastases, (50-70% of distant metstases).

DWI is a powerful imaging tool that provides unique information related to tumor cellularity, integrity of the cellular membrane, as well as the movement and functional status of the microenvironment of water in tissue. The technique can be applied widely for tumor detection, tumor characterization and monitoring of tumor response. Until recently, most sensitive radiological procedures were only limited to local coverage and could not interrogate the full body.

Diffusion-weighted sequence (DWI) of the entire body is a new promising technique feasible to evaluate multifocal disease. Technological advances and the development of the concept of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) have opened the path for routine clinical whole-body DWI, which allows detection and characterization of both oncological and non-oncological lesions throughout the entire body.

Several studies stated that; whole body magnetic resonance imaging (WB-MRI) has shown better results than skeletal scintigraphy. Practical implementation of whole body DWI, using the DWIBS concept, is relatively easy, since it can be performed on most modern MRI scanners and does not require any contrast agent administration. Furthermore, compared to SPECT/CT and PET CT, MRI scanners are more widely available and whole body DWI is less expensive.

To evaluate the value of WB DWI in detection of metastatic lesions, using bone scintigraphy for comparison.

Fifteen patients (5 males and 10 females), referred to the Radiology department of Kasr Al-Ainy Hospitals from the outpatient clinic of the Clinical Oncology department, their ages ranged between 34 to70 years, with known primary malignant tumor (confirmed histologically) underwent :- Whole body MRI including Diffusion weighted Whole body Imaging with Back ground body signal Suppression (DWIBS), Skeletal scintigraphy. Any other modality to detect extra-osseous metastases as computed tomography and ultrasound.

WB DWI Qualitative analysis was performed directly from the reformatted Malignant lesions images generally in the coronal exhibit considerably plane. Also, greater the source signal images intensities of DWI and were variability revised when on their required. profile than The benign lesions ones. were only categorized according to the subjectively WB T1-weighted, rated T2-weighted signal pattern, and signal STIR images intensity were and also morphology evaluated to without combine taking information, into account to accurately the apparent detect diffusion pathology coefficients, and rule out which artifacts were from not quantified. the diffusion-weighted sequence series.

The skeletal scintigrams were also analyzed; the increased uptake pattern of the identified lesions was rated according to the clinical experience. No quantitative measurements were considered.

RESULTS Breast carcinoma (53.3%) Prostatic carcinoma(13.3%) Bladder carcinoma(13.3%) Bronchogenic carcinoma(6.7%) Thyroid lymphoma(6.7%) Endometrial carcinoma(6.7%)

RESULTS Also, it showed the bony lesions detected by bone scan in the following sites: vertebra, sternum, femur, acetabulum, humerus, scapula, tibia, shoulder, pelvic bone, greater trochanter, clavicle, coracoid process & sacrum.

On the other hand, one rib lesion, lesions in skull & lateral condyle of femur were missed.

RESULTS The sensitivity of WB DWI in detecting metastatic bony lesions was 100% with positive predictive value = 94.7%. The sensitivity of WB DWI in detecting extraosseous lesions was 100% with positive predictive value = 100%.

Case 1 History and clinical data Female patient 33 years old who gave history of left modified radical mastectomy 3 years ago for breast carcinoma. Pathology: Invasive ductal carcinoma. Abdominal ultrasound: Multiple hepatic focal lesions.

CASES Case 1 Bone Scan Multiple metastatic osseous lesions involving sternum, head of left femur, bilateral acetabulum, DV8, LV2, 3, 4 & left 8th rib.

CASES Case 1 WB MRI A B C D E Bone metastases: Metastatic osseous lesion of sternum, bilateral acetabulum, head of left femur, DV8, LV2, 3, 4 & left 8th rib. Soft tissue metastases: Multiple liver metastases.

CASES Case 1 A WB MRI B The source axial images with the ADC=1.1 (malignant lesions).

CASES Case 2 History and clinical data 64 years old female patient with history of total thyroidectomy 1 year ago for thyroid malignancy. Pathology: Thyroid lymphoma. CT chest, abdomen & pelvis: Multiple metastatic lesions in the liver, both kidneys and right axillary LN.

Bone Scan Case 2 Multiple infiltrative osseous lesions at sacrum, DV2, 7 & 8 and posterior segment of left 7th rib.

CASES Case 2 WB MRI A B C D The source axial image (ADC=1.0) E Multiple metastatic lesions in sacrum, DV 2, 7 & 8, left 7th rib, right axillary lymph node, liver & bilaterally enlarged kidneys with multiple infiltrations.

CASES Case 3 History and clinical data 70 years old male patient with history of prostatic carcinoma. This patient was referred to us for follow up. CT chest, abdomen & pelvis: Right apical lung and bilateral suprarenal glands metastases.

Bone Scan Case 3 Multiple osseous lesions at right scapula, sternum, DV 10, right 9th & 10th ribs & its costovertebral junction and left greater trochanter.

CASES Case 3 WB MRI The primary malignant lesion is seen (prostatic carcinoma), in addition to multiple metastatic lesions in the right scapula, left humerus, sternum, DV 10 and its costovertebral junction & left 9th rib, &, left greater trochanter, AS WELL AS bilateral suprarenal glands metastases & right apical lung metastases & right 12 th rib.

A CASES WB MRI B C Case 3 D

CASES Case 3 Bone Scan

DISCUSSION In our study whole body diffusion MRI was capable to detect all extraosseous lesions (23 lesions) and most of bony lesions (107 lesions). The missed lesions were 4 lesions (two lesions in the skull, one in the rib & one in the lateral condyle of the femur).

DISCUSSION The limitation in detecting rib lesions is due to artifacts that are related to pulsation and breathing in the thorax, which make examination of the ribs, sternum and scapula more difficult. The reason for missed lesions in the skull is unclear, but may be induced by the interference of high signal in brain. Red marrow in patients (less than 40 years) causes high SI in DWI this may explain the missed lateral condyle metastatic lesion in our 38 years old female pateint by WB DWI.

LIMITATIONS The sample size was not large enough for powerful conclusion. We were unable to perform a biopsy of all skeletal metastases determined in routine examinations. The lack of a true gold standard. The standard of reference we chose was, however, the most effective method to determine lesions.

Recommendations The question of whether besides signal enhancement, quantitative assessment using the ADC values as well would further improve the results, possibly with threshold values between malignant and benign metastatic lesions, should be addressed in future studies. Larger studies using this WB DWI sequence should be performed. Comparing with other whole-body techniques such as PET/CT is recommended.

TAKE HOME MESSAGE WB-MRI WB-MRI that included DWI holds great promise, and has shown utility in the identification of both bony and visceral metastases. However, more optimization is required for WB-DWI to become a routine screening tool, and large-scale studies are needed to fully gauge its impact in oncology.